Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neurotransmitters in Prevention and Treatment of Alzheimer’s Disease
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 24, Issue 4, Pages 3841
Publisher
MDPI AG
Online
2023-02-15
DOI
10.3390/ijms24043841
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A review of potential neuropathological changes associated with ketamine
- (2022) Danica Nogo et al. Expert Opinion On Drug Safety
- Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer’s Disease
- (2022) Xincui Fang et al. Journal of Healthcare Engineering
- Molecular and Clinical Repercussions of GABA Transporter 1 Variants Gone Amiss: Links to Epilepsy and Developmental Spectrum Disorders
- (2022) Florian P. Fischer et al. Frontiers in Molecular Biosciences
- Physiology and pharmacology of amyloid precursor protein
- (2022) Yoonsuk Cho et al. PHARMACOLOGY & THERAPEUTICS
- Hippocampal Degeneration and Behavioral Impairment During Alzheimer-Like Pathogenesis Involves Glutamate Excitotoxicity
- (2021) Olayemi Joseph Olajide et al. JOURNAL OF MOLECULAR NEUROSCIENCE
- Activating mGlu3 metabotropic glutamate receptors rescues schizophrenia-like cognitive deficits through metaplastic adaptations within the hippocampus.
- (2021) Shalini Dogra et al. BIOLOGICAL PSYCHIATRY
- Protective Effects of Anti-depressant Citalopram Against Abnormal APP Processing and Amyloid Beta-induced Mitochondrial Dynamics, Biogenesis, Mitophagy and Synaptic Toxicities in Alzheimer’s Disease
- (2021) Arubala P Reddy et al. HUMAN MOLECULAR GENETICS
- Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease
- (2021) Claudia Salcedo et al. NEUROCHEMICAL RESEARCH
- Tryptophan Metabolism and Gut-Brain Homeostasis
- (2021) William Roth et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Kainate Receptors and Synaptic Plasticity
- (2021) Jithin D. Nair et al. NEUROPHARMACOLOGY
- Cholinergic System and Its Therapeutic Importance in Inflammation and Autoimmunity
- (2021) Namrita Halder et al. Frontiers in Immunology
- Memantine ameliorates cognitive deficit in AD mice via enhancement of entorhinal–CA1 projection
- (2021) Peng Li et al. BMC NEUROSCIENCE
- TREM2 Deficiency Disrupts Network Oscillations Leading to Epileptic Activity and Aggravates Amyloid-β-Related Hippocampal Pathophysiology in Mice
- (2021) Milan Stoiljkovic et al. JOURNAL OF ALZHEIMERS DISEASE
- Glutamate metabolism and recycling at the excitatory synapse in health and neurodegeneration
- (2021) Jens V. Andersen et al. NEUROPHARMACOLOGY
- Potentiation of cognitive enhancer effects of Alzheimer’s disease medication memantine by alpha7 nicotinic acetylcholine receptor agonist PHA-543613 in the Morris water maze task
- (2021) Nóra Bruszt et al. PSYCHOPHARMACOLOGY
- Dendritic/Post-synaptic Tau and Early Pathology of Alzheimer’s Disease
- (2021) Xiaomin Yin et al. Frontiers in Molecular Neuroscience
- An overview of recent analysis and detection of acetylcholine
- (2021) Xuan Gu et al. ANALYTICAL BIOCHEMISTRY
- Synaptic Input and ACh Modulation Regulate Dendritic Ca2+ Spike Duration in Pyramidal Neurons, Directly Affecting Their Somatic Output
- (2021) Amir Dudai et al. JOURNAL OF NEUROSCIENCE
- Dynamic Recovery: GABA Agonism Restores Neural Variability in Older, Poorer Performing Adults
- (2021) Poortata Lalwani et al. JOURNAL OF NEUROSCIENCE
- 5-HT Receptors and Temperature Homeostasis
- (2021) Irina P. Voronova Biomolecules
- Alzheimer’s disease: targeting the glutamatergic system
- (2020) Myra E. Conway BIOGERONTOLOGY
- Interneuron Accumulation of Phosphorylated tau Impairs Adult Hippocampal Neurogenesis by Suppressing GABAergic Transmission
- (2020) Jie Zheng et al. Cell Stem Cell
- Safety and Efficacy of Donepezil 10 mg/day in Patients with Mild to Moderate Alzheimer’s Disease
- (2020) Jianping Jia et al. JOURNAL OF ALZHEIMERS DISEASE
- Reduced Hippocampal Glutamate and Posterior Cingulate N-Acetyl Aspartate in Mild Cognitive Impairment and Alzheimer’s Disease Is Associated with Episodic Memory Performance and White Matter Integrity in the Cingulum: A Pilot Study
- (2020) Dickson Wong et al. JOURNAL OF ALZHEIMERS DISEASE
- Neurological Syndromes Associated with Anti-GAD Antibodies
- (2020) Maëlle Dade et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Regulation and roles of mitophagy at synapses
- (2020) Konstantinos Palikaras et al. MECHANISMS OF AGEING AND DEVELOPMENT
- Memory-related process in physiological status and alzheimer’s disease
- (2020) Seyedeh Nahid Fotuhi et al. MOLECULAR BIOLOGY REPORTS
- Early-stage dysfunction of hippocampal theta and gamma oscillations and its modulation of neural network in a transgenic 5xFAD mouse model
- (2020) Sitong Wang et al. NEUROBIOLOGY OF AGING
- Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease
- (2020) Alok Joshi et al. NEUROPHARMACOLOGY
- Proteomic analysis involved with synaptic plasticity improvement by GABAA receptor blockade in hippocampus of a mouse model of Alzheimer’s disease
- (2020) Keiichi Kadoyama et al. NEUROSCIENCE RESEARCH
- Mitochondrial Bioenergetics and Dynamics in Secretion Processes
- (2020) Jennyfer Martínez et al. Frontiers in Endocrinology
- Central 5-HT receptors and their function; present and future
- (2020) Trevor Sharp et al. NEUROPHARMACOLOGY
- Neural oscillations and brain stimulation in Alzheimer’s disease
- (2020) Zahra Jafari et al. PROGRESS IN NEUROBIOLOGY
- GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
- (2020) Yilan Xu et al. Frontiers in Neuroscience
- Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia
- (2020) Jean Claude Martel et al. Frontiers in Pharmacology
- The Dual Role of Glutamatergic Neurotransmission in Alzheimer’s Disease: From Pathophysiology to Pharmacotherapy
- (2020) Vidyasagar Naik Bukke et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Alterations of GABA B receptors in the APP/PS1 mouse model of Alzheimer’s Disease
- (2020) Arnold M. Salazar et al. NEUROBIOLOGY OF AGING
- Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease
- (2020) Gabriella Marucci et al. NEUROPHARMACOLOGY
- The Role of Copper in Tau-Related Pathology in Alzheimer’s Disease
- (2020) Klara Zubčić et al. Frontiers in Molecular Neuroscience
- Early alterations in hippocampal perisomatic GABAergic synapses and network oscillations in a mouse model of Alzheimer’s disease amyloidosis
- (2019) Jan-Oliver Hollnagel et al. PLoS One
- Astrocytes Maintain Glutamate Homeostasis in the CNS by Controlling the Balance between Glutamate Uptake and Release
- (2019) Shaimaa Mahmoud et al. Cells
- Dynamic compartmentalization of calcium channel signalling in neurons
- (2019) Martin Heine et al. NEUROPHARMACOLOGY
- In vivo imaging reveals reduced activity of neuronal circuits in a mouse tauopathy model
- (2019) Petar Marinković et al. BRAIN
- Mitochondrial dysfunction in Alzheimer's disease: Role in pathogenesis and novel therapeutic opportunities
- (2019) Judit M. Perez Ortiz et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuro-inflammation and anti-inflammatory treatment options for Alzheimer's disease
- (2019) Tomris Ozben et al. CLINICAL BIOCHEMISTRY
- Tau immunotherapies for Alzheimer’s disease
- (2019) Justin L. Hoskin et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Monoaminergic System Modulation in Depression and Alzheimer’s Disease: A New Standpoint?
- (2019) Maria Grazia Morgese et al. Frontiers in Pharmacology
- Aβ-induced acceleration of Alzheimer-related τ-pathology spreading and its association with prion protein
- (2019) Luis Aragão Gomes et al. ACTA NEUROPATHOLOGICA
- Lifelong choline supplementation ameliorates Alzheimer’s disease pathology and associated cognitive deficits by attenuating microglia activation
- (2019) Ramon Velazquez et al. AGING CELL
- Mechanisms and regulation of dopamine release
- (2019) Changliang Liu et al. CURRENT OPINION IN NEUROBIOLOGY
- A vicious cycle of β amyloid–dependent neuronal hyperactivation
- (2019) Benedikt Zott et al. SCIENCE
- Oral Monosodium Glutamate Administration Causes Early Onset of Alzheimer’s Disease-Like Pathophysiology in APP/PS1 Mice
- (2019) Tanja Fuchsberger et al. JOURNAL OF ALZHEIMERS DISEASE
- France removes state funding for dementia drugs
- (2019) Sebastian Walsh et al. BMJ-British Medical Journal
- GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia
- (2018) Meng-yi Xu et al. ACTA PHARMACOLOGICA SINICA
- The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
- (2018) Harald Hampel et al. BRAIN
- Glutamatergic Signaling in the Central Nervous System: Ionotropic and Metabotropic Receptors in Concert
- (2018) Andreas Reiner et al. NEURON
- Synaptogyrin-3 Mediates Presynaptic Dysfunction Induced by Tau
- (2018) Joseph McInnes et al. NEURON
- Newly Developed Drugs for Alzheimer’s Disease in Relation to Energy Metabolism, Cholinergic and Monoaminergic Neurotransmission
- (2018) Jan Korábečný et al. NEUROSCIENCE
- Cell Type-specific Intrinsic Perithreshold Oscillations in Hippocampal GABAergic Interneurons
- (2018) Young-Jin Kang et al. NEUROSCIENCE
- Glutamatergic synapses in neurodevelopmental disorders
- (2018) Edoardo Moretto et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- An Emerging Circuit Pharmacology of GABA A Receptors
- (2018) Elif Engin et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- 13 reasons why the brain is susceptible to oxidative stress
- (2018) James Nathan Cobley et al. Redox Biology
- Dopamine: Functions, Signaling, and Association with Neurological Diseases
- (2018) Marianne O. Klein et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Tau impairs neural circuits, dominating amyloid-β effects, in Alzheimer models in vivo
- (2018) Marc Aurel Busche et al. NATURE NEUROSCIENCE
- Adaptive responses of neuronal mitochondria to bioenergetic challenges: Roles in neuroplasticity and disease resistance
- (2017) Sophia M. Raefsky et al. FREE RADICAL BIOLOGY AND MEDICINE
- How Studies of the Serotonin System in Macaque Models of Menopause Relate to Alzheimer’s Disease1
- (2017) Cynthia L. Bethea et al. JOURNAL OF ALZHEIMERS DISEASE
- Therapeutics of Neurotransmitters in Alzheimer’s Disease
- (2017) Ramesh Kandimalla et al. JOURNAL OF ALZHEIMERS DISEASE
- Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
- (2017) Taro Kishi et al. JOURNAL OF ALZHEIMERS DISEASE
- Cholinergic modulation of the hippocampal region and memory function
- (2017) Juhee Haam et al. JOURNAL OF NEUROCHEMISTRY
- Functional identification of activity-regulated, high-affinity glutamine transport in hippocampal neurons inhibited by riluzole
- (2017) Jeffrey D. Erickson JOURNAL OF NEUROCHEMISTRY
- Calcium dependence of spontaneous neurotransmitter release
- (2017) Courtney L. Williams et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Adherence and Tolerability of Alzheimer's Disease Medications: A Pragmatic Randomized Trial
- (2017) Noll L. Campbell et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Metabotropic glutamate receptors and neurodegenerative diseases
- (2017) Fabiola M. Ribeiro et al. PHARMACOLOGICAL RESEARCH
- Alzheimer's disease: Targeting the Cholinergic System
- (2016) Talita H. Ferreira-Vieira et al. Current Neuropharmacology
- Gamma frequency entrainment attenuates amyloid load and modifies microglia
- (2016) Hannah F. Iaccarino et al. NATURE
- Evaluating Response to High-Dose 13.3 mg/24 h Rivastigmine Patch in Patients with Severe Alzheimer's Disease
- (2015) Martin R. Farlow et al. CNS Neuroscience & Therapeutics
- Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease
- (2015) Sagar H. Barage et al. NEUROPEPTIDES
- Galantamine treatment in outpatients with mild Alzheimer's disease
- (2014) U. Richarz et al. ACTA NEUROLOGICA SCANDINAVICA
- Pharmacological approaches for Alzheimer’s disease: neurotransmitter as drug targets
- (2014) Atish Prakash et al. Expert Review of Neurotherapeutics
- A 24-Week, Randomized, Controlled Trial of Rivastigmine Patch 13.3 mg/24 h Versus 4.6 mg/24 h in Severe Alzheimer's Dementia
- (2013) Martin R. Farlow et al. CNS Neuroscience & Therapeutics
- Regulation of neuronal GABAB receptor functions by subunit composition
- (2012) Martin Gassmann et al. NATURE REVIEWS NEUROSCIENCE
- Glutamate and GABA synthesis, release, transport and metabolism as targets for seizure control
- (2012) Nicole M. Rowley et al. NEUROCHEMISTRY INTERNATIONAL
- 5-HT4 receptor agonist mediated enhancement of cognitive function in vivo and amyloid precursor protein processing in vitro: A pharmacodynamic and pharmacokinetic assessment
- (2011) Fei Shen et al. NEUROPHARMACOLOGY
- Glutamate Receptor Ion Channels: Structure, Regulation, and Function
- (2010) S. F. Traynelis et al. PHARMACOLOGICAL REVIEWS
- A novel mechanism for GABA synthesis and packaging into synaptic vesicles
- (2009) Chandana Buddhala et al. NEUROCHEMISTRY INTERNATIONAL
- Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
- (2008) Dennis J. Selkoe BEHAVIOURAL BRAIN RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started